MYREXIS Aktie

1,96 EUR -0,5076%

Zu Ihrem Onlinebroker

kaufen verkaufen

MYREXIS Aktienkurs : 25.05. ( 15 Min. verzögert)
1,96 € Letzter Kurs	-0,51% Veränderung	1,97 € Vortag	1,96 € Eröffnungskurs

Realtime:

1,96

-0,51%

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
1,96 - 1,96 Tag	2,88 - 1,78 52 Wochen	0 Tag	2 Ø 52 Wochen	1,96 1.583 Stücke	2,01 1.531 Stücke

MYREXIS Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

25.05.

Contrarian Ideas: Are These Stocks Being Dragged Down By Excessive Pessimism?

Myrexis, Inc. (MYRX): Engages in discovering, developing, and commercializing small molecule drugs for the treatment of cancer. Market cap at $66.56M, most recent closing price at $2.49. RSI(14) indi…
25.05.

Depressed From Recent News, Myrexis' Presentation At ASCO Draws Speculation

Myrexis (MYRX) is an early-stage pharmaceutical company that focuses on the development of anti-cancer drugs whose shares are trading -41.00 % from their 52-week high ($ 4.22). The Salt Lake City, Ut…

22.05.

2 Pharmaceutical Companies Trading Below Net Cash

Since my last article in February about Myrexis (MYRX) we have seen a small pop in the share price and a subsequent drop as well. The pop was...
19.05.

An Emerging Problem

... being pushed around by ETFs include Liberty Global (LBTYB), which is part of the Fidelity NASDAQ Composite Index Tracking Stock (ONEQ); Myrexis (MYRX), by the Guggenheim Spin-Off ETF (CSD), and United Security ...
15.05.

Utah's inactive Myrexis launches new growth strategy

Myrexis Inc., a Salt Lake City-based biotechnology research company that idled much of its operations last year, said it is pursing a new long-term strategy. Part of it will be to explore acquisition…